[1]L. fx7 Fratriglioni, L.J. Launer, K. Andersen, M.M. Breteler, J.R. Copeland, J.F. Dartigues, et al.
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts.
Neurologic diseases in the elderly research group. Neurology., (2000), 54 pp. S10-S15
[2]fx7 De Pedro-Cuesta J, Virués-Ortega J, Vega S, Seijo-Martínez M, Saz P, Rodríguez F, et al., Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008. BMC Neurol. 2009; 9:55.
[3]F. fx7 Bermejo-Pareja, J. Benito-León, S. Vega, M.J. Medrano, G.C. Román.
Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence and subtypes of dementia in three elderly populations of central Spain.
J Neurol Sci., (2008), 264 pp. 63-72
[4]fx6 fx1 Manzano S, Manso R. Deterioro cognitivo vascular. En: Manzano S, Fortea J, Villarejo A, Sánchez del Valle R. editores. Guía oficial de práctica clínica en demencias. Guías diagnósticas y terapéuticas de la SEN 2018. Sociedad Española de Neurología. Madrid: Luzan; 2018. p. 153-94.
[5]García Cobos R, Frank García A. Demencia por lesión de vaso grande. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Editorial Médica Panamericana; 2010. p. 405-17.
[6]Freitas GR, Bogousslavsky J. Focal stroke syndromes. En: Erkinjuntti T, Gauthier S, editores. Vascular cognitive impairment. London: Martin Dunitz; 2002. p. 205-25.
[7]G.C. Roman, T. Erkinjuntti, A. Wallin, L. Pantoni, H.C. Chui.
Subcortical ischaemic vascular dementia.
Lancet Neurol., (2002), 1 pp. 426-436
[8]Hernández Lahoz C, Calleja Puerta S. Demencia por infarto estratégico. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Médica Panamericana; 2010. p. 429-36.
[9]Bogousslavsky J, Regli F, Uske A. Thalamic infarcts: clinical syndormes, etiology and prognosis. Nurology. 1988; 38:837-48.
[10]J.T. fx4 fx2 O’Brien, A. Thomas.
Vascular dementia.
Lancet., (2015), 386 pp. 1698-1706
[11]G.C. Román, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. García, et al.
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.
Neurology., (1993), 43 pp. 250-260
[12]P.B. Gorelick, A. Scuteri, S.E. Black, C. Decarli, S.M. Greenberg, C. Iadecola, et al.
American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing. Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association.
Stroke., (2011), 42 pp. 2672-2713
[13]W.D. Heiss, S. Zimmermann-Meinzingen.
PET imaging in the differential diagnosis of vascular dementia.
J Neurol Sci., (2012), 322 pp. 268-273
[14]fx6 fx1 Waldwmar G, Dubois B, Emre M, Georges J, McKeith IJ, Rossor M, et al., Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007; 14:e1-e26.
[15]I.G. fx6 fx2 McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, et al.
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.
Neurology., (1996), 47 pp. 1113-1124
[16]S.A. fx7 Vann Jones, J.T. O’Brien.
The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies.
Psychol Med., (2014), 44 pp. 673-683
[17]Del Ser T, Gómez Tortosa E. Demencia con cuerpos de Lewy. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Editorial Médica Panamericana; 2010. p. 289-300.
[18]Mosimann UP, Rowan En, Partington CE, Collerton D, Littlewood E, O’Brien JT, et al., Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. Am J Geriatr Psychiatry. 2006; 14:153-60.
[19]Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Vallderiola F, et al., Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegerative disorder: a descriptive study. Lancet Neurol. 2006; 5:572-7.
[20]Aarsland D, Perry R, Larsen JP, McKeith IG, O’Brien T, Perry EK, et al., Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry. 2005; 66:633-3.7
[21]McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien T, Feldman H, et al., Diagnosis and management of dementia with Lewy bodies: The third report of the DLB consortium. Neurology. 2005; 65:1863-72.
[22]I.G. fx2 McKeith, B.F. Boeve, D.W. Dickson, G. Halliday, J.P. Taylor, D. Weintraub, et al.
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Neurology., (2017), 89 pp. 1-13
[23]Z. fx4 fx2 Walker, K.L. Possing, B.F. Boeve, D. Aarsland.
Lewy body dementias.
Lancet., (2015), 386 pp. 1683-1697
[24]J.P. Taylor, I.G. McKeith, D.J. Burn, B.F. Boeve, D. Weintraub, G. Bamford, et al.
New evidence on the management of Lewy body dementia.
Lancet Neurol., (2020), 19 pp. 157-169
[25]C.U. fx7 Onykee, J. Diehl-Schmid.
The epidemiology of frontotemporal dementia.
Int Rev Psychiatry., (2013), 25 pp. 130-137
[26]Ojea Ortega T. Clínica y tratamiento de la variante conductual de la demencia frontotemporal. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Editorial Médica Panamericana; 2010. p. 321-30.
[27]J. fx4 fx2 Bang, S. Spina, B. Miller.
Frontotemporal dementia.
Lancet., (2015), 386 pp. 1672-1682
[28]N.T. fx4 fx1 Olney, S. Spina, B.L. Miller.
Frontotemporal dementia.
Neurol Clin., (2017), 35 pp. 339-374
[29]H. fx4 fx1 Sivasathiaseelan, C.R. Marshall, J.L. Agustus, E. Benhamou, R.L. Bond, J.E.P. van Leeuwen, et al.
Frontotemporal dementia: a clinical review.
Semin Neurol., (2019), 39 pp. 251-263
[30]Berthier Torres ML, Dávila Arias G. Manifestaciones clínicas y diagnóstico de las afasias primarias. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Editorial Médica Panamericana; 2010. p. 331-38.
[31]H. fx4 fx1 Botha, K.A. Josephs.
Primary progressive aphasias and apraxia of speech.
Continuum (Minneap Minn)., (2019), 25 pp. 101-127
[32]Martínez-Martín P, Kurtis MM. Parálisis supranuclear progresiva: demencia y alteraciones psicoconductuales. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Editorial Médica Panamericana; 2010. p. 339-47.
[33]Pascula-Sedano B, Kulisevsky J. Degeneración corticobasal, demencia y alteraciones psicoconductuales. En: Alberca R, López-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. 4ª ed. Madrid: Editorial Médica Panamericana; 2010. p. 349-55.
[34]K. Rascovsky, J.R. Hodges, D. Knopman, M.F. Méndez, J.H. Kramer, J. Neuhaus, et al.
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
Brain., (2011), 134 pp. 2456-2477
[35]M.L. Gorno-Tempini, A. Hillis, S. Weintraub, A. Kertesz, M. Méndez, S.F. Cappa, et al.
Classification of primary progressive aphasia and its variants.
Neurology., (2011), 76 pp. 1006-1014
[36]G.U. Hoglinger, G. Respondek, M. Stamelou, C. Kurz, K.A. Josephs, A.E. Lang, et al.
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria.
Mov Disord., (2017), 32 pp. 853-864
[37]M.J. Armstrong, I. Litvan, A.E. Lang, T.A. Bak, K.P. Bhatia, B. Borrni, et al.
Criteria for the diagnosis of corticobasal degeneration.
Neurology., (2013), 80 pp. 496-503
[38]L.H. Meeter, L.D. Kaat, J.D. Rohrer, J.C. van Swieten.
Imaging and fluid biomarkers in frontotemporal dementia.
Nat Rev Neurol., (2017), pp. 406-419
[39]F. fx5 Lebert, W. Stekke, C. Hasenbroekx, F. Pasquier.
Frontotemporal dementia: A randomized control trial with trazodone.
Dement Geriatr Cog Disord., (2004), 17 pp. 355-359
[40]fx6 fx1 Rodríguez N. Estrategias de tratamiento en la demencia frontotemporal. En: Manzano S, Fortea J, Villarejo A, Sánchez del Valle R. editores. Guía oficial de práctica clínica en demencias. Guías diagnósticas y terapéuticas de la SEN 2018. Sociedad Española de Neurología. Madrid: Luzán; 2018. p. 140-9.